Eton Pharmaceuticals, Inc.
ETON
$30.53
$0.581.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.27M | 21.28M | 22.46M | 18.93M | 17.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.27M | 21.28M | 22.46M | 18.93M | 17.28M |
| Cost of Revenue | 9.53M | 6.76M | 13.28M | 5.80M | 7.42M |
| Gross Profit | 14.74M | 14.52M | 9.18M | 13.13M | 9.86M |
| SG&A Expenses | 10.45M | 8.28M | 8.11M | 9.69M | 9.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.85M | 16.82M | 22.50M | 19.20M | 17.75M |
| Operating Income | 2.41M | 4.47M | -39.00K | -268.00K | -470.00K |
| Income Before Tax | 1.57M | 1.41M | -1.96M | -2.52M | -1.50M |
| Income Tax Expenses | 20.00K | -69.00K | -28.00K | 66.00K | 74.00K |
| Earnings from Continuing Operations | 1.55M | 1.48M | -1.93M | -2.59M | -1.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.55M | 1.48M | -1.93M | -2.59M | -1.57M |
| EBIT | 2.41M | 4.47M | -39.00K | -268.00K | -470.00K |
| EBITDA | 3.55M | 5.48M | 970.00K | 737.00K | 543.00K |
| EPS Basic | 0.06 | 0.06 | -0.07 | -0.10 | -0.06 |
| Normalized Basic EPS | 0.04 | 0.08 | -0.01 | -0.03 | -0.03 |
| EPS Diluted | 0.05 | 0.05 | -0.07 | -0.10 | -0.06 |
| Normalized Diluted EPS | 0.03 | 0.07 | -0.01 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 27.29M | 26.94M | 26.89M | 26.89M | 26.89M |
| Average Diluted Shares Outstanding | 31.55M | 31.24M | 26.89M | 26.89M | 26.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |